CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 23 enrolled
Drug / intervention
Continuous Positive Airway Pressure (CPAP) +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00801892
NCT00801892Phase 3Completed

OSA, Sleepiness, and Activity in Diabetes Management

Eileen R. Chasens·interventional·Posted Dec 4, 2008·Updated Nov 8, 2017

In Brief

A Phase 3 clinical trial evaluating Continuous Positive Airway Pressure (CPAP) and Sham- Continuous Positive Airway Pressure (Sham-CPAP) for Sleep Apnea, Obstructive and Diabetes Mellitus, Type 2. Completed, enrolled 23 participants across 1 site.

Detailed Summary

Daily physical activity is important to achieve glucose control in persons with type 2 diabetes. The purpose of this study is to explore if obstructive sleep apnea and its daytime symptom, excessive sleepiness, act as barriers to physical activity. We will examine if treatment of obstructive sleep apnea with continuous positive airway pressure results in increased physical activity in persons with type 2 diabetes.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

Phase 3CompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedDec 4, 2008
Enrollment StartApr 1, 2009
Primary CompletionApr 1, 2012
TodayJul 2, 2026
Enrollment to primary: 3 yearsPosted 17.6 years ago

Interventions

Continuous Positive Airway Pressure (CPAP)device

Mask worn over nose to splint open the airway with positive pressure to prevent the subject from holding their breath (apneas).

Sham- Continuous Positive Airway Pressure (Sham-CPAP)device

Mask worn over nose to splint open the airway with positive pressure to prevent the subject from holding their breath (apneas).